Re-Registration Norms for Medical Practitioners

Published On 2017-03-13 04:36 GMT   |   Update On 2017-03-13 04:36 GMT

The Lok Sabha was recently seen having a discussion on the re-registration policies of the government for medical practitioners. The Minister of State (Health and Family Welfare), Sh Faggan Singh Kulaste stated  in a written reply in the Lok Sabha about the norms that are followed by the government. Following is the reply:-As on date, the Indian Medical Council Act (IMC) Act, 1956, does...

Login or Register to read the full article

The Lok Sabha was recently seen having a discussion on the re-registration policies of the government for medical practitioners. The Minister of State (Health and Family Welfare), Sh Faggan Singh Kulaste stated  in a written reply in the Lok Sabha about the norms that are followed by the government. Following is the reply:-


As on date, the Indian Medical Council Act (IMC) Act, 1956, does not provide for re-registration of doctors. Medical Council of India (MCI), with the previous approval of the Central Government, has notified Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002, which, inter-alia, prescribe that a Physician should participate in professional meetings as a part of Continuing Medical Education (CME). In order to enhance professional skills and to update their medical knowledge, such CMEs must be attended by medical practitioners for at least 30 hours every 5 years, organised by reputed professional academic bodies or any other authorised organisations.


MCI or the appropriate State Medical Councils have been empowered to take disciplinary action against a doctor for violation of the provisions of the Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002. As and when complaints are received against the violation of code of ethics for doctors, such complaints are referred by MCI to the concerned State Medical Councils where the doctors/medical practitioners are registered. The MCI is an Appellate Authority. Further, there is a provision for inspection of clinical trial sites, sponsors including their subsidiaries etc. under the Drugs and Cosmetics Rules, 1945. As informed by the Drugs Controller General (India) that various irregularities were observed during such monitoring inspections during the period 2013-16 and after review of the replies received from the investigators, 12 investigators have been debarred from the conduct of future clinical trials for a period ranging between 3 months to 1 year duration.


Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News